Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)

225.01 -3.64 (-1.59%)

Streaming Delayed Price Updated: 3:35 PM EDT, Aug 17, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	971,859
Open	225.76
Bid (Size)	224.96 (40)
Ask (Size)	225.10 (40)
Prev. Close	228.65
Today's Range	222.12 - 227.99
52wk Range	197.81 - 495.55
Shares Outstanding	118,847,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ALNY Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

Today 8:45 EDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing ↗

August 16, 2026

Yes, Alnylam has had some bad news. But the bad news isn't as horrible as many think.

Via The Motley Fool

Performance

YTD	-43.8%	-43.8%
1 Month	-15.9%	-15.9%
3 Month	-21.4%	-21.4%
6 Month	-32.4%	-32.4%
1 Year	-50.7%	-50.7%

More News

NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

August 14, 2026

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth at a Reasonable Valuation ↗

August 01, 2026

Via Chartmill

Alnylam Pharmaceuticals (NASDAQ:ALNY) Plunges After Q2 Revenue Miss and Lowered Full-Year Guidance ↗

July 30, 2026

Via Chartmill

Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Priced Below Biotech Peers with Strong Growth ↗

July 17, 2026

Via Chartmill

Alnylam Pharmaceuticals (NASDAQ:ALNY) Shows Accelerating Momentum as a High Growth Stock ↗

July 14, 2026

Via Chartmill

$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today ↗

August 10, 2026

Via Benzinga

ALNYLAM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Alnylam Pharmaceuticals, Inc. on Behalf of Alnylam Stockholders and Encourages Investors to Contact the Firm

August 04, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Alnylam (ALNY) Q2 2026 Earnings Call Transcript ↗

August 03, 2026

Via The Motley Fool

ALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Alnylam Pharma (ALNY) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Via The Motley Fool

Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Alnylam Pharmaceuticals, Inc. (ALNY) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 30, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Here are the top movers in Thursday's session. ↗

July 30, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 30, 2026

Via Chartmill

Alnylam Pharmaceuticals Q2 Earnings Call Highlights ↗

July 30, 2026

Via MarketBeat

Stay updated with the stocks that are on the move in today's pre-market session. ↗

July 30, 2026

Via Chartmill

Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress

July 30, 2026

From Alnylam Pharmaceuticals, Inc.

Via Business Wire

What Happens to Stocks After Joining the Nasdaq-100 (History Has a Clear Answer) ↗

July 20, 2026

Via The Motley Fool

Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

July 16, 2026

From Alnylam Pharmaceuticals, Inc.

Via Business Wire

Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease

July 15, 2026

From Alnylam Pharmaceuticals, Inc.

Via Business Wire

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions ↗

July 13, 2026

Via MarketBeat

Discover the top movers in Thursday's pre-market session. ↗

July 09, 2026

Via Chartmill

Frequently Asked Questions

Is Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?

Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market

What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?

The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 225.01

When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 08/17/26 03:35 PM ET

What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 26.74B

How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?

Alnylam Pharmaceuticals, Inc. - Common Stock has 27B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.